PAI Holdings, LLC. dba Pharmaceutical Associates Inc 2025-02-12 Health moderate FDA
Health · FDA · Recall #FDA-D-0222-2025
Guaifenesin and Codeine Phosphate Oral Solution USP, 100mg/10 mg per 5 mL, 16 fl oz (473… Recall
Issued February 12, 2025 · PAI Holdings, LLC. dba Pharmaceutical Associates Inc
In February 2025, PAI Holdings, LLC. dba Pharmaceutical Associates Inc recalled the Guaifenesin and Codeine Phosphate Oral Solution USP, 100mg/10 mg per 5 mL, 16 fl oz (473…, a moderate health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Superpotent; sodium benzoate preservative
What you should do
- 1 Stop using Guaifenesin and Codeine Phosphate Oral Solution USP, 100mg/10 mg per 5 mL, 16 fl oz (473… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact PAI Holdings, LLC. dba Pharmaceutical Associates Inc to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- PAI Holdings, LLC. dba Pharmaceutical Associates Inc
- Category
- Health
- Recall date
- February 12, 2025
- Units affected
- Not reported
- Sold at
- OH
- Recall number
- FDA-D-0222-2025
- Made in
- United States
- Issuing agency
- FDA
In context
- PAI Holdings, LLC. dba Pharmaceutical Associates Inc has 1 recall in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 691st Health recall we've logged in 2025.